The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

Eli Lilly's direct-to-consumer platform LillyDirect has been expanded to include in-person and telehealth services for people ...

At JP Morgan 2025, pharmaphorum editor-in-chief Jonah Comstock sat down with Dr Michael Bauer, CEO of Quantro Therapeutics, about his company’s novel approach to gene transcription factor control.

The complaint filed in a Seattle court alleges that Genmab, its subsidiary ProfoundBio – which was acquired last year – and ...

“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...

Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader-Willi syndrome (PWS), a rare genetic ...

New US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he intends to save $1.8 billion per year, ...

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

Character Biosciences has raised $93m in an oversubscribed Series B round to speed the clinical development of a pipeline of ...